Monte Rosa Therapeutics, Inc. GLUE PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Monte Rosa Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The official record: Monte Rosa Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monte Rosa Therapeutics, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Monte Rosa Therapeutics, Inc.'s PP&E (net)?
- Monte Rosa Therapeutics, Inc. (GLUE) reported PP&E (net) of $28.41M in Q1 2026.
- How has Monte Rosa Therapeutics, Inc.'s PP&E (net) changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s PP&E (net) decreased by 3.2% year-over-year, from $29.34M to $28.41M.
- What is the long-term trend for Monte Rosa Therapeutics, Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), Monte Rosa Therapeutics, Inc.'s PP&E (net) has grown at a 41.2% compound annual growth rate (CAGR), from $4.62M to $25.99M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.